Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2011, Article ID 276193, 8 pages
http://dx.doi.org/10.4061/2011/276193
Review Article

Cord Blood-Derived Hematopoietic Stem/Progenitor Cells: Current Challenges in Engraftment, Infection, and Ex Vivo Expansion

1Department of Surgery, Shriners Hospitals for Children, University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA
2Institute for Translational Sciences, University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA
3Sealy Center for Molecular Medicine, University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA
4Department of Pediatrics, University of Texas Medical Branch, 815 Market Street, Galveston, TX 77550, USA

Received 10 December 2010; Revised 7 February 2011; Accepted 25 February 2011

Academic Editor: Gerald A. Colvin

Copyright © 2011 Katsuhiro Kita et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. D. Thomas, H. L. Lochte Jr., W. C. Lu, and J. W. Ferrebee, “Intravenous infusion of bone marrow in patients receiving radiation and chemotherapy,” The New England Journal of Medicine, vol. 257, no. 11, pp. 491–496, 1957. View at Google Scholar · View at Scopus
  2. N. A. Kernan, G. Bartsch, R. C. Ash et al., “Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program,” The New England Journal of Medicine, vol. 328, no. 9, pp. 593–602, 1993. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. A. Balduzzi, T. Gooley, C. Anasetti et al., “Unrelated donor marrow transplantation in children,” Blood, vol. 86, no. 8, pp. 3247–3256, 1995. View at Google Scholar · View at Scopus
  4. S. Hongeng, R. A. Krance, L. C. Bowman et al., “Outcomes of transplantation with matched-sibling and unrelated-donor bone marrow in children with leukaemia,” Lancet, vol. 350, no. 9080, pp. 767–771, 1997. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Gluckman, H. E. Broxmeyer, A. D. Auerbach et al., “Hematopoietic reconstitution in a patient with Fanconi's anemia by means of umbilical-cord blood from an HLA-identical sibling,” The New England Journal of Medicine, vol. 321, no. 17, pp. 1174–1178, 1989. View at Google Scholar · View at Scopus
  6. J. Kurtzberg, M. Laughlin, M. L. Graham et al., “Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients,” The New England Journal of Medicine, vol. 335, no. 3, pp. 157–166, 1996. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. E. Gluckman, V. Rocha, A. Boyer-Chammard et al., “Outcome of cord-blood transplantation from related and unrelated donors. Eurocord Transplant Group and the European Blood and Marrow Transplantation Group,” The New England Journal of Medicine, vol. 337, no. 6, pp. 373–381, 1997. View at Google Scholar
  8. P. Rubinstein, C. Carrier, A. Scaradavou et al., “Outcomes among 562 recipients of placental-blood transplants from unrelated donors,” The New England Journal of Medicine, vol. 339, no. 22, pp. 1565–1577, 1998. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. M. J. Laughlin, J. Barker, B. Bambach et al., “Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors,” The New England Journal of Medicine, vol. 344, no. 24, pp. 1815–1822, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. G. F. Sanz, S. Saavedra, D. Planelles et al., “Standardized, unrelated donor cord blood transplantation in adults with hematologic malignancies,” Blood, vol. 98, no. 8, pp. 2332–2338, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. G. Prindull, B. Prindull, and N. Van Der Meulen, “Haematopoietic stem cells (CFUc) in human cord blood,” Acta Paediatrica Scandinavica, vol. 67, no. 4, pp. 413–416, 1978. View at Google Scholar · View at Scopus
  12. J. J. Kirschner and J. Goldberg, “Types of colonies formed by normal human bone marrow, peripheral blood and umbilical cord blood CFUc,” Experimental Hematology, vol. 8, no. 10, pp. 1202–1207, 1980. View at Google Scholar · View at Scopus
  13. T. Nakahata and M. Ogawa, “Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors,” Journal of Clinical Investigation, vol. 70, no. 6, pp. 1324–1328, 1982. View at Google Scholar · View at Scopus
  14. Y. Ueno, S. Koizumi, M. Yamagami, M. Miura, and N. Taniguchi, “Characterization of hemopoietic stem cells (CFUc) in cord blood,” Experimental Hematology, vol. 9, no. 7, pp. 716–722, 1981. View at Google Scholar · View at Scopus
  15. G. J. Spangrude, S. Heimfeld, and I. L. Weissman, “Purification and characterization of mouse hematopoietic stem cells,” Science, vol. 241, no. 4861, pp. 58–62, 1988. View at Google Scholar · View at Scopus
  16. C. L. Li and G. R. Johnson, “Rhodamine123 reveals heterogeneity within murine Lin, Sca-1+ hemopoietic stem cells,” Journal of Experimental Medicine, vol. 175, no. 6, pp. 1443–1447, 1992. View at Publisher · View at Google Scholar · View at Scopus
  17. D. S. Krause, M. J. Fackler, C. I. Civin, and W. S. May, “CD34: structure, biology, and clinical utility,” Blood, vol. 87, no. 1, pp. 1–13, 1996. View at Google Scholar · View at Scopus
  18. R. J. Jones, M. I. Collector, J. P. Barber et al., “Characterization of mouse lymphohematopoietic stem cells lacking spleen colony-forming activity,” Blood, vol. 88, no. 2, pp. 487–491, 1996. View at Google Scholar · View at Scopus
  19. M. Osawa, K. I. Hanada, H. Hamada, and H. Nakauchi, “Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell,” Science, vol. 273, no. 5272, pp. 242–245, 1996. View at Google Scholar · View at Scopus
  20. M. A. Goodell, M. Rosenzweig, H. Kim et al., “Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species,” Nature Medicine, vol. 3, no. 12, pp. 1337–1345, 1997. View at Publisher · View at Google Scholar · View at Scopus
  21. H. Sakabe, N. Yahata, T. Kimura et al., “Human cord blood-derived primitive progenitors are enriched in CD34+c-kit- cells: correlation between long-term culture-initiating cells and telomerase expression,” Leukemia, vol. 12, no. 5, pp. 728–734, 1998. View at Google Scholar · View at Scopus
  22. M. Ogawa, Y. Matsuzaki, S. Nishikawa et al., “Expression and function of c-kit in hemopoietic progenitor cells,” Journal of Experimental Medicine, vol. 174, no. 1, pp. 63–71, 1991. View at Google Scholar · View at Scopus
  23. R. A. Briddell, V. C. Broudy, E. Bruno, J. E. Brandt, E. F. Srour, and R. Hoffman, “Further phenotypic characterization and isolation of human hematopoietic progenitor cells using a monoclonal antibody to the c-kit receptor,” Blood, vol. 79, no. 12, pp. 3159–3167, 1992. View at Google Scholar · View at Scopus
  24. W. Craig, R. Kay, R. L. Cutler, and P. M. Lansdorp, “Expression of Thy-1 on human hematopoietic progenitor cells,” Journal of Experimental Medicine, vol. 177, no. 5, pp. 1331–1342, 1993. View at Google Scholar · View at Scopus
  25. E. Deneault, S. Cellot, A. Faubert et al., “A functional screen to identify vovel effectors of hematopoietic stem cell activity,” Cell, vol. 137, no. 2, pp. 369–379, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  26. H. E. Broxmeyer, E. Srour, C. Orschell et al., “Cord blood stem and progenitor cells,” Methods in Enzymology, vol. 419, pp. 439–473, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  27. D. S. Donnelly and D. S. Krause, “Hematopoietic stem cells can be CD34+ or CD34−,” Leukemia and Lymphoma, vol. 40, no. 3-4, pp. 221–234, 2001. View at Google Scholar · View at Scopus
  28. C. P. McGuckin, D. Pearce, N. Forraz, J. A. Tooze, S. M. Watt, and R. Pettengell, “Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow,” European Journal of Haematology, vol. 71, no. 5, pp. 341–350, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. M. B. Kastan, E. Schlaffer, J. E. Russo, O. M. Colvin, C. I. Civin, and J. Hilton, “Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells,” Blood, vol. 75, no. 10, pp. 1947–1950, 1990. View at Google Scholar · View at Scopus
  30. R. W. Storms, A. P. Trujillo, J. B. Springer et al., “Isolation of primitive human hematopoietic progenitors on the basis of aldehyde dehydrogenase activity,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 16, pp. 9118–9123, 1999. View at Publisher · View at Google Scholar · View at Scopus
  31. R. A. Briddell, B. P. Kern, K. L. Zilm, G. B. Stoney, and I. K. McNiece, “Purification of CD34+ cells is essential for optimal ex vivo expansion of umbilical cord blood cells,” Journal of Hematotherapy, vol. 6, no. 2, pp. 145–150, 1997. View at Google Scholar · View at Scopus
  32. J. E. Wagner, N. A. Kernan, M. Steinbuch, H. E. Broxmeyer, and E. Gluckman, “Allogeneic sibling umbilical-cord-blood transplantation in children with malignant and non-malignant disease,” Lancet, vol. 346, no. 8969, pp. 214–219, 1995. View at Google Scholar · View at Scopus
  33. J. E. Wagner, J. Rosenthal, R. Sweetman et al., “Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft- versus-host disease,” Blood, vol. 88, no. 3, pp. 795–802, 1996. View at Google Scholar · View at Scopus
  34. A. Toren, M. Einat, I. Fabian, and A. Nagler, “Human umbilical cord blood myeloid progenitor cells are relatively chemoresistant: a potential model for autologous transplantations in HIV-infected newborns,” American Journal of Hematology, vol. 56, no. 3, pp. 161–167, 1997. View at Publisher · View at Google Scholar · View at Scopus
  35. D. T. Harris, M. J. Schumacher, J. Locascio et al., “Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 21, pp. 10006–10010, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. J. N. Barker, S. M. Davies, T. DeFor, N. K. C. Ramsay, D. J. Weisdorf, and J. E. Wagner, “Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis,” Blood, vol. 97, no. 10, pp. 2957–2961, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. A. R. Migliaccio, J. W. Adamson, C. E. Stevens, N. L. Dobrila, C. M. Carrier, and P. Rubinstein, “Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: graft progenitor cell content is a better predictor than nucleated cell quantity,” Blood, vol. 96, no. 8, pp. 2717–2722, 2000. View at Google Scholar · View at Scopus
  38. D. K. Kim, Y. Fujiki, T. Fukushima, H. Ema, A. Shibuya, and H. Nakauchi, “Comparison of hematopoietic activities of human bone marrow and umbilical cord blood CD34 positive and negative cells,” Stem Cells, vol. 17, no. 5, pp. 286–294, 1999. View at Google Scholar · View at Scopus
  39. E. S. Rosler, J. E. Brandt, J. Chute, and R. Hoffman, “An in vivo competitive repopulation assay for various sources of human hematopoietic stem cells,” Blood, vol. 96, no. 10, pp. 3414–3421, 2000. View at Google Scholar · View at Scopus
  40. A. Peled, I. Petit, O. Kollet et al., “Dependence of human stem cell engraftment and repopulation of NOD/SCID mice on CXCR4,” Science, vol. 283, no. 5403, pp. 845–848, 1999. View at Publisher · View at Google Scholar · View at Scopus
  41. C. H. Kim and H. E. Broxmeyer, “In vitro behavior of hematopoietic progenitor cells under the influence of chemoattractants: stromal cell-derived factor-1, steel factor, and the bone marrow environment,” Blood, vol. 91, no. 1, pp. 100–110, 1998. View at Google Scholar · View at Scopus
  42. K. W. Christopherson II, G. Hangoc, C. R. Mantel, and H. E. Broxmeyer, “Modulation of hematopoietic stem cell homing and engraftment by CD26,” Science, vol. 305, no. 5686, pp. 1000–1003, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  43. A. M. Lambeir, P. Proost, C. Durinx et al., “Kinetic investigation of chemokine truncation by CD26/dipeptidyl peptidase IV reveals a striking selectivity within the chemokine family,” Journal of Biological Chemistry, vol. 276, no. 32, pp. 29839–29845, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  44. K. W. Christopherson II, G. Hangoc, and H. E. Broxmeyer, “Cell surface peptidase CD26/dipeptidylpeptidase IV regulates CXCL12/stromal cell-derived factor-1α-mediated chemotaxis of human cord blood CD34+ progenitor cells,” Journal of Immunology, vol. 169, no. 12, pp. 7000–7008, 2002. View at Google Scholar · View at Scopus
  45. T. B. Campbell, G. Hangoc, Y. Liu, K. Pollok, and H. E. Broxmeyer, “Inhibition of CD26 in human cord blood CD34+ cells enhances their engraftment of nonobese diabetic/severe combined immunodeficiency mice,” Stem Cells and Development, vol. 16, no. 3, pp. 347–353, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  46. S. Saavedra, G. F. Sanz, I. Jarque et al., “Early infections in adult patients undergoing unrelated donor cord blood transplantation,” Bone Marrow Transplantation, vol. 30, no. 12, pp. 937–943, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  47. M. N. Fernández, C. Regidor, R. Cabrera et al., “Unrelated umbilical cord blood transplants in adults: early recovery of neutrophils by supportive co-transplantation of a low number of highly purified peripheral blood CD34+ cells from an HLA-haploidentical donor,” Experimental Hematology, vol. 31, no. 6, pp. 535–544, 2003. View at Publisher · View at Google Scholar · View at Scopus
  48. N. E. Timmins, E. Palfreyman, F. Marturana et al., “Clinical scale ex vivo manufacture of neutrophils from hematopoietic progenitor cells,” Biotechnology and Bioengineering, vol. 104, no. 4, pp. 832–840, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  49. K. P. Micklethwaite, B. Savoldo, P. J. Hanley et al., “Derivation of human T lymphocytes from cord blood and peripheral blood with antiviral and antileukemic specificity from a single culture as protection against infection and relapse after stem cell transplantation,” Blood, vol. 115, no. 13, pp. 2695–2703, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  50. H. J. McKenna, P. De Vries, K. Brasel, S. D. Lyman, and D. E. Williams, “Effect of flt3 ligand on the ex vivo expansion of human CD34+ hematopoietic progenitor cells,” Blood, vol. 86, no. 9, pp. 3413–3420, 1995. View at Google Scholar · View at Scopus
  51. E. Conneally, J. Cashman, A. Petzer, and C. Eaves, “Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lympho-myeloid repopulating activity in nonobese diabetic-scid/scid mice,” Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 18, pp. 9836–9841, 1997. View at Publisher · View at Google Scholar · View at Scopus
  52. V. Gabutti, F. Timeus, U. Ramenghi et al., “Expansion of cord blood progenitors and use for hemopoietic reconstitution,” Stem Cells, vol. 11, supplement 2, pp. 105–112, 1993. View at Google Scholar · View at Scopus
  53. M. R. Abboud, F. Xu, A. Payne, and J. Laver, “Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors,” Experimental Hematology, vol. 22, no. 4, pp. 388–392, 1994. View at Google Scholar · View at Scopus
  54. S. Kyoizumi, L. J. Murray, and R. Namikawa, “Preclinical analysis of cytokine therapy in the SCID-hu mouse,” Blood, vol. 81, no. 6, pp. 1479–1488, 1993. View at Google Scholar · View at Scopus
  55. T. Rossmanith, B. Schröder, G. Bug et al., “Interleukin 3 improves the ex vivo expansion of primitive human cord blood progenitor cells and maintains the engraftment potential of SCID repopulating cells,” Stem Cells, vol. 19, no. 4, pp. 313–320, 2001. View at Google Scholar · View at Scopus
  56. D. Bryder and S. E. Jacobsen, “Interleukin-3 supports expansion of long-term multilineage repopulating activity after multiple stem cell divisions in vitro,” Blood, vol. 96, no. 5, pp. 1748–1755, 2000. View at Google Scholar · View at Scopus
  57. S. Tajima, K. Tsuji, Y. Ebihara et al., “Analysis on interleukin 6 receptor and gp130 expressions and proliferative capability of human CD34+ cells,” Journal of Experimental Medicine, vol. 184, no. 4, pp. 1357–1364, 1996. View at Publisher · View at Google Scholar · View at Scopus
  58. L. F. Schipper, A. Brand, N. C. Reniers, C. J. Melief, R. Willemze, and W. E. Fibbe, “Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood,” British Journal of Haematology, vol. 101, no. 3, pp. 425–435, 1998. View at Publisher · View at Google Scholar · View at Scopus
  59. Y. Ohmizono, H. Sakabe, T. Kimura et al., “Thrombopoietin augments ex vivo expansion of human cord blood-derived heamatopoietic progenitors in combination with stem cell factor and flt3 ligand,” Leukemia, vol. 11, no. 4, pp. 524–530, 1997. View at Google Scholar · View at Scopus
  60. W. Piacibello, F. Sanavio, L. Garetto, A. Severino, A. Danè, and L. Gammaitoni, “The role of c-Mpl ligands in the expansion of cord blood hematopoietic progenitors,” Stem Cells, vol. 16, supplement 1, pp. 243–248, 1998. View at Google Scholar · View at Scopus
  61. F. Shapiro, B. Pytowski, S. Rafii et al., “The effects of Flk-2/flt3 ligand as compared with c-kit ligand on short-term and long-term proliferation of CD34+ hematopoietic progenitors elicited from human fetal liver, umbilical cord blood, bone marrow, and mobilized peripheral blood,” Journal of Hematotherapy, vol. 5, no. 6, pp. 655–662, 1996. View at Google Scholar · View at Scopus
  62. H. J. McKenna, K. L. Stocking, R. E. Miller et al., “Mice lacking flt3 ligand have deficient hematopoiesis affecting hematopoietic progenitor cells, dendritic cells, and natural killer cells,” Blood, vol. 95, no. 11, pp. 3489–3497, 2000. View at Google Scholar · View at Scopus
  63. X. Sui, K. Tsuji, R. Tanaka et al., “gp130 and c-Kit signalings synergize for ex vivo expansion of human primitive hemopoietic progenitor cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 92, no. 7, pp. 2859–2863, 1995. View at Publisher · View at Google Scholar · View at Scopus
  64. Y. Ebihara, K. Tsuji, S. D. Lyman et al., “Synergistic action of Flt3 and gp130 signalings in human hematopoiesis,” Blood, vol. 90, no. 11, pp. 4363–4368, 1997. View at Google Scholar · View at Scopus
  65. Y. Yonemura, H. Ku, F. Hirayama, L. M. Souza, and M. Ogawa, “Interleukin 3 or interleukin 1 abrogates the reconstituting ability of hematopoietic stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 93, no. 9, pp. 4040–4044, 1996. View at Publisher · View at Google Scholar · View at Scopus
  66. M. V. D. Soares, N. J. Borthwick, M. K. Maini, G. Janossy, M. Salmon, and A. N. Akbar, “IL-7-dependent extrathymic expansion of CD45RA+ T cells enables preservation of a naive repertoire,” Journal of Immunology, vol. 161, no. 11, pp. 5909–5917, 1998. View at Google Scholar · View at Scopus
  67. L. Lazzari, S. Lucchi, P. Rebulla et al., “Long-term expansion and maintenance of cord blood haematopoietic stem cells using thrombopoietin, Flt3-ligand, interleukin (IL)-6 and IL-11 in a serum-free and stroma-free culture system,” British Journal of Haematology, vol. 112, no. 2, pp. 397–404, 2001. View at Publisher · View at Google Scholar · View at Scopus
  68. T. A. Davis, D. H. Robinson, K. P. Lee, and S. W. Kessler, “Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors,” Blood, vol. 85, no. 7, pp. 1751–1761, 1995. View at Google Scholar · View at Scopus
  69. L. A. Milner, R. Kopan, D. I. K. Martin, and I. D. Bernstein, “A human homologue of the Drosophila developmental gene, Notch, is expressed in CD34+ hematopoietic precursors,” Blood, vol. 83, no. 8, pp. 2057–2062, 1994. View at Google Scholar · View at Scopus
  70. K. Ohishi, B. Varnum-Finney, and I. D. Bernstein, “Delta-1 enhances marrow and thymus repopulating ability of human CD34+CD38 cord blood cells,” Journal of Clinical Investigation, vol. 110, no. 8, pp. 1165–1174, 2002. View at Publisher · View at Google Scholar · View at Scopus
  71. C. Delaney, S. Heimfeld, C. Brashem-Stein, H. Voorhies, R. L. Manger, and I. D. Bernstein, “Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution,” Nature Medicine, vol. 16, no. 2, pp. 232–236, 2010. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. C. Delaney, B. Varnum-Finney, K. Aoyama, C. Brashem-Stein, and I. D. Bernstein, “Dose-dependent effects of the Notch ligand Delta1 on ex vivo differentiation and in vivo marrow repopulating ability of cord blood cells,” Blood, vol. 106, no. 8, pp. 2693–2699, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. A. E. Boitano, J. Wang, R. Romeo et al., “Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells,” Science, vol. 329, no. 5997, pp. 1345–1348, 2010. View at Google Scholar
  74. B. O. Palsson, S. H. Paek, R. M. Schwartz et al., “Expansion of human bone marrow progenitor cells in a high cell density continuous perfusion system,” Nature Biotechnology, vol. 11, no. 3, pp. 368–372, 1993. View at Google Scholar · View at Scopus
  75. L. K. Nielsen, “Bioreactors for haematopoietic cell culture,” Annual Review of Biomedical Engineering, vol. 1, pp. 129–152, 1999. View at Google Scholar · View at Scopus
  76. Y. Liu, T. Liu, X. Fan, X. Ma, and Z. Cui, “Ex vivo expansion of hematopoietic stem cells derived from umbilical cord blood in rotating wall vessel,” Journal of Biotechnology, vol. 124, no. 3, pp. 592–601, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. M. Valbonesi, G. Giannini, F. Migliori, R. D. Costa, and A. M. Dejana, “Cord blood (CB) stem cells for wound repair: preliminary report of 2 cases,” Transfusion and Apheresis Science, vol. 30, no. 2, pp. 153–156, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. L. Crisa, V. Cirulli, K. A. Smith, M. H. Ellisman, B. E. Torbett, and D. R. Salomon, “Human cord blood progenitors sustain thymic T-cell development and a novel form of angiogenesis,” Blood, vol. 94, no. 11, pp. 3928–3940, 1999. View at Google Scholar · View at Scopus